In the entire cohort and target therapy subgroup, Kaplan–Meier curves showed a marginal trend in predicting disease progression among patients with MTVlfn, TLGlfn, MTVsoft + lfn, TLG soft + lfn, MTVwb and TLGwb lower or higher than the median values ( Figure 3 for the entire cohort and Figure 4 for the target therapy cohort). 4.
← all excerpts
Predictive Value of Baseline [18F]FDG PET/CT for Response to Systemic Therapy in Patients with Advanced Melanoma.
1
—
—